Investigational New Drugs,volume 23,issue 2  (01-2014)

Period of time: 2014年2期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 23,issue 2

Menu

Transient respiratory failure possibly associated to imatinib

By Lengerke C.,Brümmendorf T.,Herrlinger U.,Horger M.,Kanz L.,Hartmann J. in (2005)

Investigational New Drugs,volume 23,issue 2 , Vol. 23, Iss. 2, 2005-01 , pp. 137-138

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

By Schmid Peter,Schweigert Marcus,Beinert Thomas,Flath Bernd,Sezer Orhan,Possinger Kurt in (2005)

Investigational New Drugs,volume 23,issue 2 , Vol. 23, Iss. 2, 2005-01 , pp. 139-146

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer

By MacKenzie Mary,Hirte Holger,Glenwood Goss,Jean Maroun,Goel Rakesh,Major Pierre,Miller Jr. Wilson,Panasci Lawrence,Lorimer Ian,Batist Gerald,Matthews Sarah,Douglas Lynn,Seymour Lesley in (2005)

Investigational New Drugs,volume 23,issue 2 , Vol. 23, Iss. 2, 2005-01 , pp. 165-170

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

By Ta-Chung Chao,Zyting Chu,Ling-Ming Tseng,Tzeon-Jye Chiou,Ruey-Kuen Hsieh,Wei-Shu Wang,Chueh-Chuan Yen,Muh-Hwa Yang,Liang-Tsai Hsiao,Jin-Hwang Liu,Po-Min Chen in (2005)

Investigational New Drugs,volume 23,issue 2 , Vol. 23, Iss. 2, 2005-01 , pp. 171-177

Springer Publishing Company

Abstract Access to resources Recommend Favorite